Terms: = Uterine cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
1996 results:
1. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract] [Full Text] [Related]
2. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
4. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
[TBL] [Abstract] [Full Text] [Related]
5. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
7. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract] [Full Text] [Related]
8. Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
Li W; Ma L; Li F; Li K; Zhang Y; Ren H; Bao X; Guo Y; Guo Y; Wang M; Li D; Duan Y; Ma X; Wang Z; Wang Y; Yin R
Radiat Oncol; 2024 Apr; 19(1):46. PubMed ID: 38594678
[TBL] [Abstract] [Full Text] [Related]
9. A Comparative Study of Deep Learning Dose Prediction Models for Cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
10. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
[TBL] [Abstract] [Full Text] [Related]
11. A prior-information-based automatic segmentation method for the clinical target volume in adaptive radiotherapy of cervical cancer.
Wang X; Chang Y; Pei X; Xu XG
J Appl Clin Med Phys; 2024 May; 25(5):e14350. PubMed ID: 38546277
[TBL] [Abstract] [Full Text] [Related]
12. Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
Gao Y; Gonzalez Y; Nwachukwu C; Albuquerque K; Jia X
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537309
[No Abstract] [Full Text] [Related]
13. Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
Zhang XF; Wu HY; Liang XW; Chen JL; Li J; Zhang S; Liu Z
BMC Womens Health; 2024 Mar; 24(1):182. PubMed ID: 38504245
[TBL] [Abstract] [Full Text] [Related]
14. Preterm Birth Following Active Surveillance vs Loop Excision for Cervical Intraepithelial Neoplasia Grade 2.
Lycke KD; Kahlert J; Eriksen DO; Omann C; Pedersen LH; Sundtoft I; Landy R; Petersen LK; Hammer A
JAMA Netw Open; 2024 Mar; 7(3):e242309. PubMed ID: 38483389
[TBL] [Abstract] [Full Text] [Related]
15. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
Graça J; Preti M; Pollano B; Vieira-Baptista P
J Low Genit Tract Dis; 2024 Apr; 28(2):131-136. PubMed ID: 38465957
[TBL] [Abstract] [Full Text] [Related]
16. uterine transposition for fertility preservation in pelvic cancers.
Ribeiro R; Baiocchi G; Obermair A; Costa CN; Leitao M
Int J Gynecol Cancer; 2024 Mar; 34(3):403-408. PubMed ID: 38438174
[TBL] [Abstract] [Full Text] [Related]
17. The effects of laparoscopic and laparotomy extensive hysterectomy on the safety of ureterovaginal fistula infection in patients with cervical cancer.
Xu H; Ding H; Ge Q; Shi C
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):281-284. PubMed ID: 38431837
[TBL] [Abstract] [Full Text] [Related]
18. Mismatch repair status and surgical approach in apparent early-stage endometrial cancer.
Morton R; Webb PM; Na R; Obermair A; Farrell R
Int J Gynecol Cancer; 2024 Apr; 34(4):535-543. PubMed ID: 38431289
[TBL] [Abstract] [Full Text] [Related]
19. Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis.
Bartoletti M; Montico M; Lorusso D; Mazzeo R; Oaknin A; Musacchio L; Scambia G; Puglisi F; Pignata S
Cancer Treat Rev; 2024 Apr; 125():102701. PubMed ID: 38422895
[TBL] [Abstract] [Full Text] [Related]
20. Adherence to treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia.
Stroetmann CY; Gizaw M; Alemayehu R; Wondimagegnehu A; Rabe F; Santos P; Mchome B; Mmbaga BT; Addissie A; Kantelhardt EJ
Oncologist; 2024 May; 29(5):e655-e664. PubMed ID: 38394385
[TBL] [Abstract] [Full Text] [Related]
[Next]
